Seeking Alpha

Galapagos N.V. ADR (GLPYY)

- OTCPK - Current
  • EP Vantage | Send Message 16 Apr

    Galapagos Moves Towards RA Deal But A Dark Horse Remains On The Horizon $GLPGF, $GLPYY
      • SNJBiostoxx | Send Message 14 Dec 2014

        SNJ-Biostoxx 2015 Favorites Off To A Flying Start Already In 2014 $EXAS, $GLPGF, $GLPYY
          • User 020 | Send Message 9 Dec 2014

            $GLPGF $GLPYY Galapagos CEO fears takeover by partner Abbvie. In Monday Dutch Newspaper FD, he claims the stock is way to low at 14 euro.
              • SNJBiostoxx | Send Message 28 Nov 2014

                SNJ-Biostoxx' Favorite Biotech Stocks For 2015 $EXAS, $MXDHF, $GLPYY
                  • SNJBiostoxx | Send Message 20 Nov 2014

                    SNJ-Biostoxx Expects 4 Positive Press Releases By Galapagos Within The Next Few Weeks. $GLPYY
                      • SNJBiostoxx | Send Message 20 Nov 2014

                        SNJ-Biostoxx expects 4 stock-moving press releases by $GLPGF $GLPYY $GLPG within the next few weeks. See
                          • SNJBiostoxx | Send Message 17 Nov 2014

                            $GLPGF $GLPYY Galapagos presents results potential blockbuster GLPG0634 at ACR 2014. Good safety + efficacy:
                              Visit Seeking Alpha's
                              GLPYY vs. ETF Alternatives
                              Company Description
                              Galapagos is a midsized biotechnology company, with therapeutic programs based on proprietary disease modifying drug targets, and a focus on inflammation, orphan disease, and anti-infectives. Galapagos' approach is to develop drugs that stop or reverse a disease state using novel targets that... More
                              Sector: Healthcare
                              Country: Belgium